| Title |
Comparative Efficacy for Infliximab Vs Vedolizumab in Biologic Naive Ulcerative Colitis
|
|---|---|
| Published in |
Clinical Gastroenterology and Hepatology, July 2022
|
| DOI | 10.1016/j.cgh.2021.07.038 |
| Pubmed ID | |
| Authors |
Neeraj Narula, Emily C.L. Wong, John K. Marshall, Jean-Frederic Colombel, Parambir S. Dulai, Walter Reinisch |
Twitter Demographics
The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 7 | 19% |
| Spain | 4 | 11% |
| Canada | 2 | 5% |
| United Kingdom | 2 | 5% |
| France | 2 | 5% |
| China | 1 | 3% |
| India | 1 | 3% |
| Australia | 1 | 3% |
| Mexico | 1 | 3% |
| Other | 4 | 11% |
| Unknown | 12 | 32% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 25 | 68% |
| Scientists | 7 | 19% |
| Practitioners (doctors, other healthcare professionals) | 4 | 11% |
| Science communicators (journalists, bloggers, editors) | 1 | 3% |
Mendeley readers
The data shown below were compiled from readership statistics for 28 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 28 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 4 | 14% |
| Student > Ph. D. Student | 3 | 11% |
| Student > Doctoral Student | 2 | 7% |
| Other | 2 | 7% |
| Student > Postgraduate | 2 | 7% |
| Other | 3 | 11% |
| Unknown | 12 | 43% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 9 | 32% |
| Computer Science | 2 | 7% |
| Immunology and Microbiology | 2 | 7% |
| Agricultural and Biological Sciences | 1 | 4% |
| Pharmacology, Toxicology and Pharmaceutical Science | 1 | 4% |
| Other | 1 | 4% |
| Unknown | 12 | 43% |
Attention Score in Context
This research output has an Altmetric Attention Score of 32. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 July 2022.
All research outputs
#1,161,096
of 24,162,843 outputs
Outputs from Clinical Gastroenterology and Hepatology
#429
of 4,490 outputs
Outputs of similar age
#26,572
of 425,835 outputs
Outputs of similar age from Clinical Gastroenterology and Hepatology
#13
of 114 outputs
Altmetric has tracked 24,162,843 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,490 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 16.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 425,835 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 114 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.